Elevance Health's financial outlook for FY 2025 anticipates GAAP diluted earnings per share (EPS) to be in the range of $30.40 to $31.10 and adjusted diluted EPS to be in the range of $34.15 to $34.85 ...
Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
(Reuters) -Elevance Health on Thursday posted quarterly profit slightly above Wall Street expectations, helped by lower-than-expected spending on medical care for its members. The results lifted ...
The year 2024 was exceptional for US stocks, with the broader market climbing over 23% and the […] (Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged ...
Wall Street was mixed in premarket trading on Thursday as major U.S. airlines stumbled and health insurance companies soared ...
Elevance Health led the insurance sector higher after it beat Wall Street’s sales and profit targets and raised its dividend.
The share of in-network federal health insurance exchange plan claims denied in 2023 was the highest since 2015, according to ...
Barnes Drug Store is an independent pharmacy in the south Georgia town of Valdosta that's been serving the community for a ...
The lawsuit – which has been anticipated since the FTC published a damning report on the PBM sector in July – names CVS Health's Caremark, UnitedHealth Group's Optum, and Cigna's Express ...
U.S. stocks are drifting near a record as Wall Street’s recent rally loses some momentum. Elevance Health led the insurance ...